D.E. Shaw & Co’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

D.E. Shaw & Co’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-10,909	Closed	-$266K	–	3956
2017 Q4	$266K	Sell	10,909 -2,288	-17%	-$44K	﹤0.01%	3293
2017 Q3	$244K	Buy	+13,197	New	+$229K	﹤0.01%	3222
2016 Q3	–	Sell	-27,226	Closed	-$497K	–	3675
2016 Q2	$497K	Buy	27,226 +108	+0.4%	+$1.86K	﹤0.01%	2804
2016 Q1	$493K	Buy	27,118 +9,947	+58%	+$161K	﹤0.01%	2796
2015 Q4	$290K	Buy	+17,171	New	+$292K	﹤0.01%	3379
2015 Q3	–	Sell	-17,400	Closed	-$450K	–	4036
2015 Q2	$450K	Sell	17,400 -17,722	-50%	-$448K	﹤0.01%	3219
2015 Q1	$769K	Buy	+35,122	New	+$758K	﹤0.01%	2752

D.E. Shaw & Co's ENTL Position: Q1 2018 in Review

D.E. Shaw & Co sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 10,909 shares — an estimated $266K sold.

D.E. Shaw & Co first reported a position in ENTL in Q1 2015 and held it in 7 quarters. The position peaked at $769K in Q1 2015. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

D.E. Shaw & Co reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
D.E. Shaw & Co sold 10,909 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $266K.
D.E. Shaw & Co first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 7 quarters.
D.E. Shaw & Co's Entellus Medical, Inc. Common Stock position peaked at $769K in Q1 2015.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on D.E. Shaw & Co's 13F filing for Q1 2018, filed 15 May 2018.